Clinical trials
Placebo clinical trials
Below are recruiting placebo clinical trials, each written for real people, not researchers. We’re tracking 5,158 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06849076Recruiting
Ankle joint motion and body awareness after stroke
This study tests if a hands-on ankle treatment can improve your sense of where your ankle is in space (proprioception) after a stroke. It looks at how well you can feel and control your ankle movement.
Bolu, MerkezAges 45–75 - NCT06853223RecruitingPhase 2
Immune drug to prevent lung transplant failure
This trial tests an immune-suppressing medicine to stop a serious complication called primary graft dysfunction that can happen soon after a lung transplant. It may help people who are already on the transplant waiting list and plan to receive a standard anti-rejection drug regimen.
San Francisco, CaliforniaAges 18 years+ - NCT06854393RecruitingPhase 2
Lacripep Eye Drops for Faster Healing After PRK
This study is testing a new eye drop called Lacripep to see if it helps heal the cornea (the clear front part of the eye) faster after PRK laser vision correction. It is for active-duty military members and their families who are already planning to have PRK surgery.
Fort Belvoir, VirginiaAges 21–55 - NCT06853665RecruitingPhase 4
Study of mixed amphetamine for autism and ADHD in teens
This trial tests if a mixed amphetamine medication helps teenagers with both autism and ADHD who still have significant symptoms, even if they are already on other treatments. It also includes typically developing teens as a comparison group.
Boston, MassachusettsAges 8–18 - NCT06855433RecruitingPhase 2
Colchicine for CPPD: reducing pain and inflammation
This trial tests if colchicine can reduce pain and swelling in people with CPPD (calcium pyrophosphate deposition disease), a type of arthritis. If you have had a swollen, red, or warm joint in the last 3 months and your pain is moderate or higher, this study may offer a possible treatment.
Birmingham, AlabamaAges 40 years+ - NCT06848894Enrolling by invitation
Study of a drug for stroke patients after blood clot treatment
This trial tests if adding a drug called human urinary kallidinogenase (HUK) can improve recovery for people who have had a stroke and already received clot-busting medicine or a procedure to remove the clot. The goal is to see if it helps reduce disability after a stroke.
Beijing, Beijing MunicipalityAges 18 years+ - NCT06853327Enrolling by invitationPhase 2
Ketorolac for pain during IUD insertion
This study tests if a pain-relief medicine, ketorolac, helps reduce pain when getting an IUD placed. It might be an option if you are planning to have an IUD inserted.
Hillsborough, North CarolinaAges 18 years+ - NCT06857487RecruitingPhase 1/Phase 2
Testing an herb formula to prevent early stroke worsening
This study tests a traditional Chinese herb formula called Qingre Huatan to see if it can stop stroke symptoms from getting worse in the first few days. It is for people who have had an ischemic stroke within the last 48 hours and are at high risk for early decline.
Beijing, Beijing MunicipalityAges 18–80 - NCT06853015RecruitingPhase 1/Phase 2
Double dose of 4-AP for spinal cord injury recovery
This study tests whether a higher dose of a drug called 4-AP can help improve leg movement and function after a spinal cord injury. It is for people who have had a spinal cord injury at or above the lower back and can already move their ankle and hip slightly.
Chicago, IllinoisAges 18–85 - NCT04987775RecruitingEarly Phase 1
Study of NAC for Gulf War illness in veterans
This early-stage study tests the treatment called NAC to understand how it may work in veterans with Gulf War illness–related symptoms like fatigue and brain/mood changes. It also looks at “mechanisms,” meaning what’s happening in the body and brain while you’re in the study.
Palo Alto, CaliforniaAges 47–70 - NCT06576466Recruiting
Creatine for stroke recovery
This study tests whether taking a daily creatine supplement for a few weeks can help people recover movement better after a recent clot-caused stroke. If you've had a stroke in the past 1 to 5 days and need rehab for weakness or coordination issues, you may be able to join.
Palma de Mallorca, Balearic IslandsAges 18–80 - NCT06842199RecruitingPhase 3
Testing a new pill for moderate to severe plaque psoriasis
This trial tests an experimental drug called ICP-488 for people with moderate to severe plaque psoriasis. It aims to see if the drug can improve symptoms and is safe, and may be an option if you need stronger treatment than creams or light therapy.
Hefei, AnhuiAges 18–75 - NCT06845839RecruitingPhase 1
Testing a new drug in healthy volunteers
This trial tests a new drug called CAY001 in healthy volunteers to see how safe it is and how the body processes it. It may help researchers understand if the drug is safe enough to test in people with medical conditions later.
Fair Lawn, New JerseyAges 18–50 - NCT06842966RecruitingPhase 2
Testing a new tablet for chronic gallbladder issues
This trial tests an investigational tablet for people with long-term gallbladder inflammation (chronic cholecystitis) or bile duct movement problems (biliary dyskinesia). It aims to see if the tablet reduces stomach pain and other digestive symptoms.
Engel'sAges 18–70 - NCT06836609RecruitingPhase 1/Phase 2
Study of a new drug for fatty liver disease (MASLD/MASH)
This study tests a new drug called ALN-CIDEB for people with fatty liver disease (MASLD or MASH). The goal is to see if it can reduce liver fat and improve liver health. You may qualify if you have a higher BMI and evidence of liver fat on imaging tests.
Chandler, ArizonaAges 18–65 - NCT06846320RecruitingPhase 2
Study of ABBV-932 for generalized anxiety disorder
This trial tests an oral medicine called ABBV-932 when added to current antidepressant therapy for people with generalized anxiety disorder (GAD) who still have symptoms. It aims to see if the combination can improve anxiety and reduce side effects.
Huntsville, AlabamaAges 18–65 - NCT06845553RecruitingPhase 2
Vutiglabridin for knee osteoarthritis: a phase 2 study
This trial tests an experimental pill called Vutiglabridin for people with knee osteoarthritis. It aims to see if the drug is safe and effective at reducing knee pain and improving function.
Seongnam-si, Gyeonggi-doAges 40–75 - NCT06839131RecruitingPhase 1
Study of SPH9788 tablets in healthy Chinese volunteers
This trial tests a new medicine called SPH9788 in healthy people to see how the body handles it. Volunteers must be generally healthy and follow lifestyle rules to help researchers understand the drug's safety and effects.
ShanghaiAges 18–45 - NCT06842173RecruitingPhase 1/Phase 2
Safety testing of new bird flu vaccine (H5N8) in adults
This trial tests a new bird flu (H5N8) vaccine for adults aged 18 and older. It looks at how safe the vaccine is and how well it triggers an immune response. The vaccine is given as a shot and includes an adjuvant to boost protection.
Belo Horizonte, Minas GeraisAges 18 years+ - NCT06839144RecruitingPhase 2
Medications before surgery to slow ovarian cancer growth
This trial tests whether giving two common medications before and after surgery can slow the growth of ovarian cancer. The medications may help reduce stress signals that could make cancer spread faster during surgery.
Ramat GanAges 20–85 - NCT06577558RecruitingPhase 2
SR1375 for severe pneumonia not improving on antibiotics
This trial tests a new drug called SR1375 for adults with severe community-acquired pneumonia (a lung infection) who are not improving with standard antibiotics. It may help reduce inflammation and speed up recovery.
Fuyang, AnhuiAges 18–85 - NCT06845124RecruitingPhase 2
Testing CBD and naltrexone for alcohol craving
This trial is testing if taking cannabidiol (CBD) plus naltrexone can reduce alcohol craving in people with alcohol dependence. Naltrexone is already used to help with alcohol cravings, and CBD may add extra benefit.
Wiesloch, Baden-WurttembergAges 18–70 - NCT06837857RecruitingPhase 2
Opioid pain relief study for older adults with chronic pain
This study tests whether a carefully managed prescription opioid can safely help older adults with long-term pain that hasn't been relieved by other pain medicines. The goal is to see if it improves pain without harming memory or brain health.
Rochester, MinnesotaAges 65 years+ - NCT06843148Recruiting
Does niacin help move fat from liver to fat tissue?
This study tests if niacin (a B vitamin) can help the body store fat safely in fat tissue instead of letting it build up in the liver. It may be an option for people with fatty liver linked to belly fat, without serious liver damage or other health issues.
Sherbrooke, QuebecAges 20–80
Hear when a new Placebo trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for placebo?
- Yes. Clin2 currently lists 5,158 recruiting placebo studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a placebo trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a placebo trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.